RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Depreciation & amortization

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndDepreciation & amortization (Million USD)YoY (%)
Jun 30, 2025198+12.21%
Jun 30, 2024177+7.09%
Jun 30, 2023165+3.48%
Jun 30, 2022160+1.82%
Jun 30, 2021157+1.23%
Jun 30, 2020155+2.69%
Jun 30, 2019151+25.70%
Jun 30, 2018120+6.96%
Jun 30, 2017112+29.14%
Jun 30, 201687+18.88%
Jun 30, 201573-0.54%
Jun 30, 201473-6.17%
Jun 30, 201378-8.82%
Jun 30, 201286+21.58%
Jun 30, 201171

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)